What is the upside for ObsEva (OBS) stock?
ObsEva SA Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover This edition features ESG pitfalls amid mineral resources, the …
Where can I buy shares of obsv?
Apr 11, 2022 · Real-time trade and investing ideas on ObsEva OBSV from the largest community of traders and investors.
What are analysts'target prices for ObsEva's stock?
Apr 01, 2022 · ObsEva's stock was trading at $2.57 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OBSV stock has decreased by 44.0% and is now trading at $1.44. View which stocks have been most impacted by COVID-19.
How much is a share of ObsEva worth?
Apr 08, 2022 · View ObsEva SA OBSV investment & stock information. Get the latest ObsEva SA OBSV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Is OBSV a good stock to buy?
Is OBSEVA SA Stock a good buy in 2022, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: OBSV) stock is to Strong Buy OBSV stock.
Will OBSV stock go up?
Stock Price Forecast The 2 analysts offering 12-month price forecasts for Obseva SA have a median target of 11.50, with a high estimate of 12.00 and a low estimate of 11.00. The median estimate represents a +733.33% increase from the last price of 1.38.
What does ObsEva company do?
Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy.
Is ObsEva a buy right now?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ObsEva in the last twelve months. There are currently 2 buy ratings for th...
How has ObsEva's stock price been impacted by Coronavirus (COVID-19)?
ObsEva's stock was trading at $2.57 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organizat...
When is ObsEva's next earnings date?
ObsEva is scheduled to release its next quarterly earnings announcement on Thursday, May 5th 2022. View our earnings forecast for ObsEva .
How were ObsEva's earnings last quarter?
ObsEva SA (NASDAQ:OBSV) posted its earnings results on Thursday, November, 4th. The company reported $0.01 earnings per share for the quarter, topp...
What price target have analysts set for OBSV?
2 brokers have issued 12-month target prices for ObsEva's stock. Their forecasts range from $15.00 to $21.00. On average, they expect ObsEva's shar...
Who are ObsEva's key executives?
ObsEva's management team includes the following people: Brian O'Callaghan , Chief Executive Officer & Director William M. Brown , Chief Financia...
Who are some of ObsEva's key competitors?
Some companies that are related to ObsEva include Mersana Therapeutics (MRSN) , Khosla Ventures Acquisition (KVSA) , LianBio (LIAN) , Nkarta (N...
What other stocks do shareholders of ObsEva own?
Based on aggregate information from My MarketBeat watchlists, some companies that other ObsEva investors own include Sorrento Therapeutics (SRNE)...
When did ObsEva IPO?
(OBSV) raised $98 million in an initial public offering on Thursday, January 26th 2017. The company issued 6,500,000 shares at $14.00-$16.00 per sh...
Premium Research for OBSV
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Signals & Forecast
ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman's reproductive health and pregnancy. ObsEva SA is headquartered in Geneva, Switzerland.
Support, Risk & Stop-loss
A buy signal was issued from a pivot bottom point on Friday, February 18, 2022, and so far it has risen 9.52%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price.
Is ObsEva SA stock A Buy?
ObsEva SA finds support from accumulated volume at $1.36 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Golden Star Signal
ObsEva SA holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
OBSV earnings per share forecast
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
OBSV revenue forecast
What is OBSV 's earnings per share in the next 3 years based on estimates from 1 analyst?
